Top 50 Ra Capital Management L P Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S - ADR | 24.92% | 10.28M | $2.35B | +0.00%(+0) | $87.12(+215.08%) | 2026-03-31 | |
| PCVX | VAXCYTE INC | 7.07% | 11.47M | $666.8M | +6.99%(+750.00K) | $45.61(+28.01%) | 2026-03-31 | |
| RYTM | RHYTHM PHARMACEUTICALS INC | 6.14% | 6.67M | $579.8M | +0.00%(+0) | $39.03(+192.48%) | 2026-03-31 | |
| TYRA | TYRA BIOSCIENCES INC | 4.95% | 12.20M | $467.2M | +0.00%(+0) | $16.23(+88.63%) | 2026-03-31 | |
| SION | SIONNA THERAPEUTICS INC | 4.21% | 9.91M | $397.1M | +0.00%(+0) | $10.46(+320.55%) | 2026-03-31 | |
| EWTX | EDGEWISE THERAPEUTICS INC | 3.48% | 10.43M | $328.5M | +0.00%(+0) | $17.96(+120.31%) | 2026-03-31 | |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 3.24% | 9.55M | $305.7M | +0.00%(+0) | $13.90(+150.53%) | 2026-03-31 | |
| NUVL | NUVALENT INC-A | 2.75% | 2.53M | $259.6M | +34.79%(+654.09K) | $89.51(+38.22%) | 2026-03-31 | |
| DNTH | DIANTHUS THERAPEUTICS INC | 2.32% | 2.61M | $219.2M | +62.05%(+1.00M) | $39.48(+138.95%) | 2026-03-31 | |
| MLYS | MINERALYS THERAPEUTICS INC | 2.21% | 7.69M | $208.4M | +5.04%(+369.00K) | $16.98(+63.12%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +12.27% | +41.50% |
| Top 20 Holdings Unweighted | +13.69% | +46.96% |
Sign up free to track Ra Capital Management L P, compare funds side by side, and get alerts the moment positions change.